MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

CUSIP: 61559X104

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 6 signals
Share change
+385,839
SEC-reported price per share
$7.76
Number of holders
24
Value change
+$3,123,162
Number of buys
9
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
80,766,491

Security key

61559X104

Report period

Q3 2022

Institutions

24

Top holders

10

Ownership snapshot

Top reported holders of MLTX - MoonLake Immunotherapeutics - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Helix Holdings LLC
Disclosed value leader
Helix Holdings LLC
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5 13F Highest disclosed value: $192,569,820 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Helix Holdings LLC has the largest disclosed position value at $192.57M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Helix Holdings LLC's linked filing trail.
Disclosed position value Top 5
Helix Holdings LLC $192.57M
BVF INC/IL $114.19M
Cormorant Asset Management, LP $30.89M
CITADEL ADVISORS LLC $13.92M
TCG Crossover Management, LLC $5.25M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Helix Holdings LLC
3/4/5
Former 10% Holder
—
denominator unverified
$192,569,820
3,215,000 shares
— 05 Apr 2022
BVF INC/IL
13F
Company
13F
—
denominator unverified
$114,194,000
21,751,284 shares
— 30 Jun 2022
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$30,886,000
6,065,001 shares
— 30 Jun 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$13,916,000
2,702,661 shares
— 30 Jun 2022
TCG Crossover Management, LLC
13F
Company
13F
—
denominator unverified
$5,250,000
1,000,000 shares
— 30 Jun 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$4,439,000
870,524 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
24
Shares
36,855,847
Rows available
24
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
22
Q3 2022 holders
24
Holder diff
2
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .